Elanco Animal Health (ELAN) Capital Expenditures (2017 - 2026)

Elanco Animal Health has disclosed Capital Expenditures across 10 years of filings, most recently posting $51.0 million for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $51.0 million, down 21.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $262.0 million (up 39.36% YoY), and the FY2025 annual result was $276.0 million, up 87.76% from the prior year.
• Capital Expenditures came in at $51.0 million for Q1 2026 at Elanco Animal Health, down from $62.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $92.0 million in Q3 2025 to a low of $7.0 million in Q1 2022.
• The 5-year median for Capital Expenditures is $42.0 million (2023), against an average of $46.2 million.
• Peak annual rise in Capital Expenditures reached 250.0% in 2022, while the deepest fall reached 47.97% in 2022.
• Elanco Animal Health's Capital Expenditures stood at $77.0 million in 2022, then sank by 46.75% to $41.0 million in 2023, then climbed by 14.63% to $47.0 million in 2024, then jumped by 31.91% to $62.0 million in 2025, then declined by 17.74% to $51.0 million in 2026.
• The last three Capital Expenditures figures came in at $51.0 million (Q1 2026), $62.0 million (Q4 2025), and $92.0 million (Q3 2025), per Business Quant data.